Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 60%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 50% · refreshes every 15s during session
Limited proprietary earnings coverage for NRSN yet — signals will sharpen as filings and earnings are ingested.
Pipeline evidence · 77d ago
NRSN's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on NRSN.
Free accounts see more of this; Premium sees all of it.
Updated
What happened recently for NeuroSense Therapeutics Ltd. (NRSN) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
NRSN's AI investment thesis
Upgrade to Premium for NRSN's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Latest price
$6.62
Market cap
$215.53M
Profitable
No
Net income
$-11.13M
FY Dec 31, 2025
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
US equity research on AlphaOS
Investment Snapshot above is the primary AlphaOS analysis for NeuroSense Therapeutics Ltd. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow NeuroSense Therapeutics Ltd. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.